RW

Raphael Wisniewski

Directeur associé

Greater Paris Metropolitan Region

Investor
VC

Invests in

Stages:

Series B
Series A

Sectors:

Medical Devices
Pharmaceuticals
Digital Health
Health & Hospital Services
Health IT

Locations:

Paris, France
  • Min Investment:

    $5,000,000.00
  • Max Investment:

    $35,000,000.00
  • Target Investment:

    $20,000,000.00

Education

  • HP

    HEC Paris

    (1990 - 1993)

Lists including Raphael

AT
AS
AT
AH

All Series A Investors

14748 people

Investments

ENYO Pharma

Series B

Total Funding: $90M

BioVentrix

Series A

Total Funding: $49M

Andera Partners

Series A

Total Funding: $49M

SoniVie

Series C

Total Funding: $60M

Amolyt Pharma

Series C

Total Funding: $290M

ImCheck Therapeutics

Series C

Total Funding: $180M

Exciva

Series A

Total Funding: $10M

Artios Pharma

Series B

Total Funding: $270M

ReViral

Series A

Total Funding: $120M

AM Pharma

Series F

Total Funding: $210M

Vessix Vascular

Series B

Total Funding: $23M

Work Experience

AP
Andera Partners

2001

  • Associé

    2001

GS
Goldman Sachs

1999 - 2001

  • Associate

    1999 - 2001

Salomon Brothers

1996 - 1999

  • Analyst

    1996 - 1999

All information is sourced from public domain and might be inaccurate.

|

By continuing, you're agreeing to our Terms and Privacy Policy.

|

Learn more About The Network.